Ashley V Makela1,2, Jeffrey M Gaudet1,2, and Paula J Foster1,2
1Medical Biophysics, Western University, London, ON, Canada, 2Robarts Research Institute, London, ON, Canada
Synopsis
Tumour associated macrophages (TAMs) are correlated with an aggressive tumour type and poor outcomes. This study is the first time iron and fluorine-19 (19F) based MRI cell tracking methods have been compared for the detection and quantification of TAMs in an orthotopic model of breast cancer. Imaging was performed at 4 days and 3 weeks post cell implantation. Both cell tracking methods showed a much higher TAM density at 4 days; no other imaging study has examined this at such an early time point. 19F MRI provided quantitative information about TAM density and tumoural distribution that was not possible with iron.Introduction
Tumour-associated macrophages (TAMs)
are associated with tumour growth and metastatic spread.
1 Breast tumours can be comprised of up to
50% TAMs
2 and their presence is correlated with a poor
outcome.
3 Cell tracking with MRI can be used to
image TAMs. Previous studies have shown that iron oxide particles (USPIO)
administered intravenously (IV) are preferentially taken up by TAMs and that
signal loss on MR images corresponds to TAMs identified by histopathology.
4 Quantification of TAMs with iron-based
cell tracking is challenging; the degree of signal loss produced by iron
labeled cells is only linear at low iron concentrations.
5 Studies that use iron-based cell tracking usually
measure the volume of signal loss or percentage of black pixels, which is
influenced by the blooming artifact induced by iron. Fluorine-19 (
19F)
MRI is another method being developed to track and quantify cells in vivo.
19F
has some major advantages, with the ability to image perfluorocarbon (PFC)-labeled
cells with high specificity due to the lack of endogenous fluorine in
biological tissues. Most importantly,
19F MRI is quantitative, since
the signal intensity is linearly related to the number of
19F-labeled
cells. Therefore, it may be used to
quantify the number of macrophages in vivo. This study is
the first time iron-based and
19F-based cell tracking methods have been compared for TAM detection and
quantification.
Methods
4T1 cells were implanted
orthotopically into the inguinal mammary fat pad in female BALB/c mice. Four
groups of mice were studied. For Groups 1&2, MRI was performed as soon as
tumours were palpable (3 days post implantation (p.i.)). For Groups 3&4, MRI
was performed 3 weeks p.i. All images were acquired using a balanced steady
state free precession (bSSFP) pulse sequence.
Iron-Based Cell Tracking: Mice in Groups 1&3 were
imaged at 3T pre and 24 hours post IV injection of a USPIO. Spatial
resolution was 200x200x200 μm
3.
19F-Based Cell Tracking: Mice
in Groups 2&4 were imaged at 9.4T using a dual-tuned
1H/
19F
birdcage coil, at 48 hours post IV injection of a red fluorescent PFC. Spatial resolution
was 0.5x0.5x1.0 mm
3. A
1H/
19F overlay was composed
for anatomical reference.
Analysis
For Groups 1&3, pre and post iron images were
compared to visualize the distribution of signal loss. The percentage of black
pixels within the total tumour volume was determined from post iron images. For
Groups 3&4, the number of
19F atoms per mm
3 was quantified
by relating the detected
19F signal within the tumour to the signal
generated by a reference tube containing a known amount of
19F atoms
and dividing by tumour volume. Tumours were examined using fluorescence
microscopy to detect the red fluorescence of the PFC. Perls Prussian Blue (PPB)
was used to stain for iron and anti-lectin antibody was used (DAB and green
fluorescence) to identify macrophages.
Results/Discussion
Figure 1 shows
results for tumours detected at 3 days p.i. (1A) is a post-iron MRI in which
the signal loss encompasses nearly the entire tumor volume. Histology (1B&C)
shows iron-positive cells and macrophages distributed throughout the tumour.
19F
signal distribution is similar (1D); since
19F signal is
proportional to the number of
19F atoms, these images provide more
information than the post-iron images, revealing that the signal is higher in
the central region (white) compared to the periphery (red) at this early time point.
The presence of the PFC in the tumour is confirmed with fluorescence
microscopy. Figure 2 shows images obtained at 3 weeks p.i. At this time point
the signal loss observed post-iron (2B) appears around the periphery of the
tumour and corresponds very well with the iron staining (2C).
19F MRI
(2D) locates the
19F signal also around the tumour periphery but appears
to occupy less area and may better represent the actual cell distribution since
there is not the same sort of blooming artifact due to iron in
19F images.
The presence of TAMs is confirmed in 2E&F (brown). Figure 3 shows PFC (red)
and positive macrophages (green) along with the
19F MRI obtained at
3 weeks. Quantification of images is illustrated in Figure 4. Both cell
tracking methods suggest that there is a higher density of TAMs present in the
tumours at 4 days. No other cell tracking study has looked at TAMs at such an
early time point during tumour progression.
Conclusion
The use of
19F-based
cell tracking may provide a more accurate representation of TAM infiltration
when compared to iron-based cell tracking. This is achieved through both the
ability to quantify
19F atoms as well as the lack of blooming
artifact as seen with iron-labeled cells.
Acknowledgements
This study was supported by the Ontario Research Fund.
AVM is funded by the CIHR Strategic Training Program in Cancer Research and Technology Transfer (CaRTT) and holds a Translational Breast Cancer Studentship funded in part by the Breast Cancer Society of Canada. Further support is provided by the Western University Molecular Imaging Collaborative Program.
References
1. Yang J, Li X, Liu X, Liu Y. The role of
tumor-associated macrophages in breast carcinoma invasion and metastasis. Int
J Clin Exp Pathol. 2015;8(6):6656-6664.
2. Kelly
PM, Davison RS, Bliss E, McGee JO. Macrophages in human breast disease: a
quantitative immunohistochemical study. Br J Cancer. 1988;57(2):174-177.
3. Bingle
L, Brown NJ, Lewis CE. The role of tumour-associated macrophages in tumour
progression: Implications for new anticancer therapies. J Pathol.
2002;196(3):254-265.
4. Daldrup-Link
HE, Golovko D, Ruffell B, et al. MRI of tumor-associated macrophages with
clinically applicable iron oxide nanoparticles. Clin Cancer Res. 2011;17(17):5695-5704.
5. Heyn
C, Bowen C V., Rutt BK, Foster PJ. Detection threshold of single SPIO-labeled
cells with FIESTA. Magn Reson Med. 2005;53(2):312-320.